
Nanobiotix SA
NBTXHealthcare|Biotechnology|France
$39.95
+1.12 (+2.88%)
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812",
"202912",
"203012"
],
"revenue_estimate": [
56.89,
86.49,
87.2,
97.6,
159.28
],
"ebit_estimate": [
12.44,
27.95,
12.17,
20.98,
66.86
],
"ebitda_estimate": [
-15.04,
43.35,
null,
null,
null
],
"net_income_estimate": [
-1.75,
20.75,
8.59,
10.84,
52.24
],
"per_share_eps_estimate": [
0.05,
-0.01,
0.18,
-0.19,
-0.07
],
"eps_nri_estimate": [
-0.34,
0.04,
-0.14,
0.17,
0.92
],
"dividend_estimate": [
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
0.27,
-0.08,
-0.98,
null,
null
],
"pretax_income_estimate": [
8.21,
7.38,
13.83,
10.96,
58.08
],
"operating_cash_flow_per_share_estimate": [
0.74,
-0.1,
-0.29,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null
],
"roe_estimate": [
-45.47,
-456.1,
-6.35,
null,
null
],
"gross_margin_estimate": [
100,
100,
99.35,
94,
93
],
"operating_cash_flow_estimate": [
35.72,
-4.95,
-14.08,
null,
null
],
"pettm_estimate": [
832.29,
0,
228.29,
0,
0
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "58.00",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": 58,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [
"202606",
"202612"
],
"revenue_estimate": [
null,
null
],
"ebit_estimate": [
null,
null
],
"ebitda_estimate": [
null,
null
],
"net_income_estimate": [
null,
null
],
"per_share_eps_estimate": [
null,
null
],
"eps_nri_estimate": [
-0.12,
-0.12
],
"dividend_estimate": [
null,
null
],
"book_value_per_share_estimate": [
null,
null
],
"pretax_income_estimate": [
null,
null
],
"operating_cash_flow_per_share_estimate": [
null,
null
],
"roa_estimate": [
null,
null
],
"roe_estimate": [
null,
null
],
"gross_margin_estimate": [
null,
null
],
"operating_cash_flow_estimate": [
null,
null
],
"pettm_estimate": [
null,
null
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "58.00",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": 58,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}